Question 199 · LEK · Chronic coronary syndromes
In all patients with chronic coronary syndrome, irrelatively of a cardiovascular risk, comorbidities and the presence of symptoms of ischemia, in order to improve prognosis it is recommended to administer:
- A. liraglutide.
- B. angiotensin-converting-enzyme inhibitor (ACE-I).
- C. beta-adrenergic receptor antagonist.
- D. long-acting nitrate.
- E. statin.
Hint
Which drug class reduces cardiovascular events in every patient with chronic coronary syndrome regardless of other factors?
The answer, the explanation and a note on every option are available once you log in. The account is free: topic tests, a mock exam, mistake review and statistics.
More questions on Internal medicine
- A 44-year-old women with lupus nephritis diagnosed 20 years earlier comes to the emergency room because of a head injury, without any other…
- A 45-year-old professionally active woman was diagnosed with arterial hypertension. The blood pressure measured at home was 160/100 mmHg. The…
- A 72-year-old man comes to emergency unit because of diarrhoea and vomiting. The blood pressure is 90/50 mm Hg. The patient takes ramipril and…
- Which of the following does not contribute to the symptoms of sarcoidosis?
- The indications for the treatment of Helicobacter pylori infection according to Maastricht IV recommendations include:
- Which of the following tests is used to confirm the diagnosis of acute pancreatitis?